Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts

Ron 激酶抑制剂单独使用和与 PI3K 抑制剂联合使用治疗 sfRon 表达乳腺癌患者来源异种移植瘤的临床前疗效